An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of endocrinology"
DOI: 10.1530/eje-21-0509
Abstract: NTRK rearrangements represent a very rare genomic abnormality among all cancers, but can be detected in thyroid cancer with a non-negligible frequency of 2%. Dramatic clinical responses to therapies targeting NTRK chimeric proteins are now… read more here.
Keywords: response larotrectinib; thyroid carcinoma; carcinoma harboring; sqstm1 ntrk1 ... See more keywords
Remote-access hemithyroidectomy in a patient with papillary thyroid cancer after ipsilateral irradiation: a case report.
Sign Up to like & getrecommendations! Published in 2022 at "Gland surgery"
DOI: 10.21037/gs-21-715
Abstract: Remote-access thyroidectomy (RAT) is becoming a more frequently used approach that can avoid scars in the neck and provide better cosmetic results than open surgery. However, there has been no surgical indication for RAT in… read more here.
Keywords: rat; remote access; patient papillary; case ... See more keywords